← Leaderboards
Alan P Fields
University Of Texas Medical Br Galveston
$16,541,191
Attributed
$17,602,496
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,602,496 · 10
By mechanism
R01$14,482,795 · 4
R21$1,563,831 · 3
P50$1,434,125 · 1
R03$113,745 · 1
R13$8,000 · 1
Top collaborators
- Verline Justilien6 shared
- Aminah Jatoi2 shared
Most similar at University Of Texas Medical Br Galveston
Same institution · by research overlap
- Nicole R Murray$3,830,138
- Randall J Urban$29,729,784
- E Aubrey Thompson$2,793,172
Others in their field
Top investigators on “Oncogenes”
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- David Heimbrook · Leidos Biomedical Research, Inc.$73,747,183
- Scott W Lowe · Sloan-Kettering Inst Can Research$36,382,798
- John Blenis · Harvard University (Medical School)$29,103,255
- Andrea Califano · Columbia University Health Sciences$28,006,523
- Robert Neil Eisenman · Fred Hutchinson Cancer Research Center$27,166,845
Research focus
OncogenesBaseSignal TransductionTumorCancer EtiologyIn VitroGrowthCessation Of LifeProtein Kinase CCellsNon-Small-Cell Lung CarcinomaCell TransformationLungOncogenicIn VivoPhosphorylationUnited StatesMalignant Neoplasm Of LungGeneticProtein KinaseGenesLung NeoplasmsTherapeutic TargetPhenotype
Grant awards (63)
A Genetically Tractable Mouse Model for PRKCI-driven Lung Squamous Cell Carcinoma$284,301
R01 · FY2025 · CA · contact PI
A Genetically Tractable Mouse Model for PRKCI-driven Lung Squamous Cell Carcinoma$340,095
R01 · FY2024 · CA · contact PI
A Genetically Tractable Mouse Model for PRKCI-driven Lung Squamous Cell Carcinoma$350,834
R01 · FY2023 · CA · contact PI
Protein Kinase C Signaling Mechanisms in Cancer$469,424
R01 · FY2022 · CA · contact PI
A Genetically Tractable Mouse Model for PRKCI-driven Lung Squamous Cell Carcinoma$350,834
R01 · FY2022 · CA · contact PI
Investigating cells of origin and oncogenic modifiers of 3q26-driven LUSC$73,693
R01 · FY2022 · CA · contact PI
Protein Kinase C Signaling Mechanisms in Cancer$479,004
R01 · FY2021 · CA · contact PI
A Genetically Tractable Mouse Model for PRKCI-driven Lung Squamous Cell Carcinoma$357,994
R01 · FY2021 · CA · contact PI
Protein Kinase C Signaling Mechanisms in Cancer$53,210
R01 · FY2021 · CA · contact PI
Protein Kinase C Signaling Mechanisms in Cancer$479,004
R01 · FY2020 · CA · contact PI
Therapeutic targeting of Kras-driven Lung Adenocarcinoma$357,994
R01 · FY2020 · CA · contact PI
Three-Dimensional Organoid Cultures to Investigate 3q26 Driver Functions in Multiple Lung Cancer Cells of Origin$53,210
R01 · FY2020 · CA · contact PI
Protein Kinase C Signaling Mechanisms in Cancer$470,306
R01 · FY2019 · CA · contact PI
Therapeutic targeting of Kras-driven Lung Adenocarcinoma$347,253
R01 · FY2019 · CA · contact PI
Project 6 - PKC Iota$319,254
P50 · FY2019 · CA · contact PI
Protein Kinase C Signaling Mechanisms in Cancer$479,004
R01 · FY2018 · CA · contact PI
Therapeutic targeting of Kras-driven Lung Adenocarcinoma$357,994
R01 · FY2018 · CA · contact PI
Project 6 - PKC Iota$285,250
P50 · FY2018 · CA · contact PI
Protein Kinase C Signaling Mechanisms in Cancer$391,250
R01 · FY2017 · CA · contact PI
Therapeutic targeting of Kras-driven Lung Adenocarcinoma$357,994
R01 · FY2017 · CA · contact PI
Project 6 - PKC Iota$285,273
P50 · FY2017 · CA · contact PI
Protein Kinase C Signaling Mechanisms in Cancer$391,250
R01 · FY2016 · CA · contact PI
Therapeutic targeting of Kras-driven Lung Adenocarcinoma$357,994
R01 · FY2016 · CA · contact PI
Project 6 - PKC Iota$272,554
P50 · FY2016 · CA · contact PI
Protein Kinase C Signaling Mechanisms in Cancer$391,250
R01 · FY2015 · CA · contact PI
Project 6 - PKC Iota$271,794
P50 · FY2015 · CA · contact PI
The pathophysiology and palliation of the paclitaxel-induced acute pain syndrome$172,095
R21 · FY2015 · CA
Protein Kinase C Signaling Mechanisms in Cancer$379,513
R01 · FY2014 · CA · contact PI
The pathophysiology and palliation of the paclitaxel-induced acute pain syndrome$192,765
R21 · FY2014 · CA
Protein Kinase C Signaling Mechanisms in Cancer$391,250
R01 · FY2013 · CA · contact PI
Protein Kinase C Signaling Mechanisms in Cancer$414,986
R01 · FY2012 · CA · contact PI
Combined PKCiota and mTOR inhibition for treatment of advanced squamous lung canc$327,704
R21 · FY2012 · CA · contact PI
Lipid Signaling Pathways in Cancer$2,000
R13 · FY2012 · CA · contact PI
Protein Kinase C Signaling Mechanisms in Cancer$417,869
R01 · FY2011 · CA · contact PI
Combined PKCiota and mTOR inhibition for treatment of advanced squamous lung canc$341,960
R21 · FY2011 · CA · contact PI
Atypical PKC signaling in lung cancer stem cells$196,207
R21 · FY2011 · CA · contact PI
Atypical PKC signaling in lung cancer stem cells$84,196
R21 · FY2011 · CA · contact PI
Protein Kinase C Signaling Mechanisms in Cancer$438,109
R01 · FY2010 · CA · contact PI
Atypical PKC signaling in lung cancer stem cells$168,563
R21 · FY2010 · CA · contact PI
Atypical PKC signaling in lung cancer stem cells$80,341
R21 · FY2010 · CA · contact PI
Protein Kinase C Signaling Mechanisms in Cancer$430,738
R01 · FY2009 · CA · contact PI
Lipid Signaling Pathways in Cancer$6,000
R13 · FY2009 · CA · contact PI
Role of Protein Kinase C in Colon Carcinogenesis$424,034
R01 · FY2008 · CA · contact PI
Role of Protein Kinase C in Colon Carcinogenesis$422,576
R01 · FY2007 · CA · contact PI
Role of Protein Kinase C in Colon Carcinogenesis$425,339
R01 · FY2006 · CA · contact PI
Role of Protein Kinase C in Colon Carcinogenesis$425,775
R01 · FY2005 · CA
Protein Kinase C in Colon Carcinogenesis$413,742
R01 · FY2004 · CA
PROTEIN KINASE C AND COLON CARCINOGENESIS$648,014
R01 · FY2003 · CA
PROTEIN KINASE C AND COLON CARCINOGENESIS$44,972
R01 · FY2003 · CA
PROTEIN KINASE C AND COLON CARCINOGENESIS$351,104
R01 · FY2002 · CA
PROTEIN KINASE C ISOTYPES IN LEUKEMIA CELL PHYSIOLOGY$339,747
R01 · FY2002 · CA
PROTEIN KINASE C ISOTYPES IN LEUKEMIA CELL PHYSIOLOGY$34,966
R01 · FY2002 · CA
LIPID SIGNALLING IN THE CELL NUCLEUS$28,296
R03 · FY2002 · TW
LIPID SIGNALLING IN THE CELL NUCLEUS$9,584
R03 · FY2002 · TW
PROTEIN KINASE C AND COLON CARCINOGENESIS$335,038
R01 · FY2001 · CA
PROTEIN KINASE C ISOTYPES IN LEUKEMIA CELL PHYSIOLOGY$233,248
R01 · FY2001 · CA
PROTEIN KINASE C ISOTYPES IN LEUKEMIA CELL PHYSIOLOGY$99,812
R01 · FY2001 · CA
LIPID SIGNALLING IN THE CELL NUCLEUS$38,090
R03 · FY2001 · TW
PROTEIN KINASE C ISOTYPES IN LEUKEMIA CELL PHYSIOLOGY$33,947
R01 · FY2001 · CA
PROTEIN KINASE C AND COLON CARCINOGENESIS$324,417
R01 · FY2000 · CA
PROTEIN KINASE C ISOTYPES IN LEUKEMIA CELL PHYSIOLOGY$226,750
R01 · FY2000 · CA
LIPID SIGNALLING IN THE CELL NUCLEUS$37,775
R03 · FY2000 · TW
PROTEIN KINASE C ISOTYPES IN LEUKEMIA CELL PHYSIOLOGY$32,957
R01 · FY2000 · CA